Clinical Trials Directory

Trials / Completed

CompletedNCT03124069

A Development Study to Evaluate a Nasal Mask for the Treatment of Obstructive Sleep Apnea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Fisher and Paykel Healthcare · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This investigation is designed to evaluate the comfort, ease of use and performance of a trial nasal mask for the treatment of Obstructive Sleep Apnea (OSA) in the home environment.

Detailed description

The investigation is a prospective, non-randomized, non-blinded study. Up to 45 OSA patients who currently use a nasal or nasal pillows mask will be recruited This study will involve a baseline (Visit One) data gathering with the participant's PAP therapy and their usual mask. This will be followed by the participants being fitted with the trial nasal mask for use in-home (Visit Two). The participant then will come in to return the mask (Visit Three) and give feedback on their experience using the mask in home in the form of a structured interview during Visit Three. The maximum amount of time the participants will be exposed to the trial mask in-home will be 14 ± 5 days from Visit Two. The mask and CPAP (if used from the loan research pool) will be returned to the institution at the conclusion of the trial and participant will return to their usual mask and therapy device for the treatment of Obstructive Sleep Apnea. Neither the investigators nor the participants will be blinded to the study.

Conditions

Interventions

TypeNameDescription
DEVICEF&P SaturnParticipants will be placed on this arm for a total of 14 ± 5 days from Visit 2. Participants will be using the trial nasal mask during this treatment arm.

Timeline

Start date
2017-04-24
Primary completion
2017-05-26
Completion
2017-09-30
First posted
2017-04-21
Last updated
2021-07-14
Results posted
2021-07-14

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03124069. Inclusion in this directory is not an endorsement.